Payment overview · 2025
General Payments
$18.87
1 reported records · 1 companies
Healthcare provider profile · identity verified
Olivia Helitha Cronin, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · INDIANAPOLIS, IN · NPI 1881820249
Verified facts
What the public records show
CMS Open Payments records show Olivia Helitha Cronin, M.D. received $18.87 in general payments during 2025 across 1 reported records.
Exact Sciences Corporation accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $18.87 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $18.87 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| The Cologuard Plus Collection Kit Normalized: the cologuard plus collection kit |
Device | Exact Sciences Corporation | $18.87 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 385 | 50 |
| Levothyroxine Sodium | Levothyroxine Sodium | 306 | 44 |
| Amlodipine Besylate | Amlodipine Besylate | 255 | 38 |
| Furosemide | Furosemide | 230 | 43 |
| Potassium Chloride | Potassium Chloride | 211 | 37 |
| Sertraline Hcl | Sertraline Hcl | 211 | 32 |
| Donepezil Hcl | Donepezil Hcl | 187 | 31 |
| Gabapentin | Gabapentin | 177 | 32 |
| Eliquis | Apixaban | 158 | 25 |
| Metoprolol Succinate | Metoprolol Succinate | 148 | 24 |
| Lisinopril | Lisinopril | 143 | 24 |
| Famotidine | Famotidine | 142 | 21 |
| Tamsulosin Hcl | Tamsulosin Hcl | 139 | 21 |
| Pantoprazole Sodium | Pantoprazole Sodium | 138 | 19 |
| Trazodone Hcl | Trazodone Hcl | 131 | 31 |
| Omeprazole | Omeprazole | 124 | 23 |
| Duloxetine Hcl | Duloxetine Hcl | 105 | 20 |
| Simvastatin | Simvastatin | 103 | 14 |
| Memantine Hcl | Memantine Hcl | 102 | 16 |
| Losartan Potassium | Losartan Potassium | 100 | 16 |
| Mirtazapine | Mirtazapine | 92 | 16 |
| Metoprolol Tartrate | Metoprolol Tartrate | 91 | 18 |
| Buspirone Hcl | Buspirone Hcl | 90 | 21 |
| Clopidogrel | Clopidogrel Bisulfate | 83 | suppressed |
| Carvedilol | Carvedilol | 82 | 14 |
| Allopurinol | Allopurinol | 73 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 73 | 16 |
| Escitalopram Oxalate | Escitalopram Oxalate | 73 | 15 |
| Torsemide | Torsemide | 73 | 16 |
| Metformin Hcl | Metformin Hcl | 71 | 13 |
| Montelukast Sodium | Montelukast Sodium | 70 | suppressed |
| Spironolactone | Spironolactone | 70 | 12 |
| Xarelto | Rivaroxaban | 68 | suppressed |
| Risperidone | Risperidone | 64 | 11 |
| Alendronate Sodium | Alendronate Sodium | 60 | 11 |
| Amiodarone Hcl | Amiodarone Hcl | 56 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 56 | suppressed |
| Levetiracetam | Levetiracetam | 54 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 50 | 11 |
| Aripiprazole | Aripiprazole | 48 | suppressed |
| Tradjenta | Linagliptin | 48 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 45 | suppressed |
| Baclofen | Baclofen | 43 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 41 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 38 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 36 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 35 | suppressed |
| Myrbetriq | Mirabegron | 35 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 34 | 15 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 33 | suppressed |
| Jardiance | Empagliflozin | 33 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 33 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 32 | suppressed |
| Cephalexin | Cephalexin | 31 | 14 |
| Entresto | Sacubitril/Valsartan | 31 | suppressed |
| Nifedipine Er | Nifedipine | 31 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 30 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 30 | suppressed |
| Olanzapine | Olanzapine | 30 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 29 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 28 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 27 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 27 | suppressed |
| Gemtesa | Vibegron | 26 | suppressed |
| Irbesartan | Irbesartan | 26 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 26 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 26 | suppressed |
| Finasteride | Finasteride | 25 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 25 | suppressed |
| Meloxicam | Meloxicam | 25 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 25 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 24 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 24 | suppressed |
| Bupropion Xl | Bupropion Hcl | 23 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 23 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 23 | suppressed |
| Glipizide | Glipizide | 22 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 21 | suppressed |
| Novofine Autocover | Pen Needle, Diabetic, Safety | 21 | suppressed |
| Linzess | Linaclotide | 20 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 20 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 19 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 19 | suppressed |
| Trulicity | Dulaglutide | 19 | suppressed |
| Lamotrigine | Lamotrigine | 18 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 18 | suppressed |
| Nystatin | Nystatin | 17 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 17 | suppressed |
| Ondansetron Odt | Ondansetron | 16 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 16 | suppressed |
| Loperamide | Loperamide Hcl | 15 | 12 |
| Metolazone | Metolazone | 15 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 14 | 11 |
| Glipizide Er | Glipizide | 14 | suppressed |
| Januvia | Sitagliptin Phosphate | 14 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 14 | suppressed |
| Alprazolam | Alprazolam | 13 | suppressed |
| Atenolol | Atenolol | 13 | suppressed |
| Clozapine | Clozapine | 13 | suppressed |
| Digoxin | Digoxin | 13 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 13 | suppressed |
| Leflunomide | Leflunomide | 13 | suppressed |
| Pentoxifylline | Pentoxifylline | 13 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 13 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 13 | suppressed |
| Balsalazide Disodium | Balsalazide Disodium | 12 | suppressed |
| Bumetanide | Bumetanide | 12 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 12 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 12 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 12 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 12 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 12 | suppressed |
| Biktarvy | Bictegrav/Emtricit/Tenofov Ala | 11 | suppressed |
| Candesartan Cilexetil | Candesartan Cilexetil | 11 | suppressed |
| Fenofibrate | Fenofibrate | 11 | suppressed |
| Glimepiride | Glimepiride | 11 | suppressed |
| Lactulose | Lactulose | 11 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 11 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 11 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 11 | suppressed |
| Vilazodone Hcl | Vilazodone Hcl | 11 | suppressed |
| Zonisamide | Zonisamide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $18.87 · 1 records | Exact Sciences Corporation | The Cologuard Plus Collection Kit | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error